Roka Bioscience Raises $20 Million
Roka Bioscience revealed that it has completed a Series C round of equity financing, raising $20M.
Roka Bioscience revealed that it has completed a Series C round of equity financing, raising $20M.
According to a report released by the Institute of Medicine (IOM) Friday, the U.S. Food and Drug Administration needs to develop a new regulatory framework to replace the 35-year-old 510(k) clearance process for medical devices.
Paul Keckley noted that things may get worse before they get better in the healthcare and lifescience industry in the United States.
Inovio Pharmaceuticals reported Friday the positive long-term effects of its VGX-3100 vaccine, designed to treat cervical dysplasia and cancer caused by the human papillomavirus, or HPV.
GSV Capital Founder & CEO Michael Moe interviewed by OneMedRadio. GSV raised $50 million in an IPO in May 2011 to invest in emerging technology companies.
For many emerging companies, one of their largest financial investments and most important strategic decisions is their approach to sales and distribution.
After bringing his clinical research software company back from near bankruptcy to steady profitability in 2010, CEO Larry Birch is going on the offensive.
Thursday the 14th July 2011, Intercontinental New York Barclay Hotel, 111 East 48th Street, New York The directors of IntelliCell BioSciences (PINK: CWLC) will be […]
e-Zassi is the medical device industry’s first subscription-based, decision support software and technology marketplace.
The Management’s Guide to Wall Street & the Capital Markets Thursday, July 28th, 2011 – New York City Gansevoort Park Avenue Hotel 420 Park Avenue […]
Copyright © 2024 | WordPress Theme by MH Themes